Silva Pharmaceuticals Limited announcements
119 Dhaka Stock Exchange announcements for Silva Pharmaceuticals Limited (SILVAPHL) since 2018: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2018 (5).
- Q1 Financials
(Q1 Un-audited): EPS was Tk. 0.48 for July-September, 2018 as against Tk. 0.21 for July-September, 2017; NOCFPS was Tk. 0.18 for July-September, 2018 as against Tk. 0.30 for July-September, 2017. NAV per share was Tk. 15.79 as on September 30, 2018 and Tk. 17.11 as on June 30, 2018.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 13, 2018 at 4:00 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended on September 30, 2018.
- Trading of New Security
Trading of the shares of Silva Pharmaceuticals Limited will commence at DSE from today i.e. October 10, 2018 under 'N' category. DSE Trading Code for Silva Pharmaceuticals Limited is "SILVAPHL" and DSE Company Code is 18493.
- Prohibition on providing loan facilities to purchase securities
DSE NEWS: The Stock Brokers, Merchant Bankers and Portfolio Managers are requested to abstain from providing loan facilities to purchase securities of Silva Pharmaceuticals Limited in between 1st to 30th trading day starting from today i.e. October 10, 2018 as per BSEC Directive No. SEC/CMRRCD/2009-193/177 and BSEC Order No. SEC/CMRRCD/2009-193/178 dated October 27, 2015.
- Audited Financials
Silva Pharmaceuticals Limited: As per audited annual financial statements, Profit after tax was Tk. 92.99 million and basic EPS was Tk. 0.93 for the year ended on 30 June 2018 as against profit after tax of Tk. 80.28 million and basic EPS of Tk. 1.03 for the previous year ended on 30 June 2017. However, Post-IPO basic EPS for the year ended on 30 June 2018 would be Tk. 0.72. (cont.) (Continuation news of SILVAPHL): On the other hand, NAV per share (considering Pre-IPO paid up shares) was Tk. 17.11 as on 30 June 2018 and the same would be Tk. 15.47 (considering Post-IPO paid up shares). Weighted average Pre-IPO paid-up number of shares was 100,000,000 for the year ended on 30 June 2018 and 77,818,082 for the year ended on 30 June 2017. Post-IPO number of paid-up shares would be 130,000,000. (end)
Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.